Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert James Wills currently holds 32,241 shares of CymaBay Therapeutics, Inc. (CBAY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert James Wills has been a net buyer of CBAY stock. They have purchased $714.8K and sold $8.9K worth of shares.
Robert James Wills's most recent insider trade was on Aug 21, 2026, when they purchased 10,000 shares at $9.62 per share.
Robert James Wills serves as Executive at CymaBay Therapeutics, Inc. (CBAY). They have executed 37 insider transactions totaling $723.7K over their tenure at the company.
Robert James Wills holds the position of Executive at CymaBay Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Robert James Wills has shown a buying trading pattern, with $714.8K in total purchases and $8.9K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert James Wills was on Aug 18, 2025, when they purchased $127.3K worth of ACOG shares. This transaction involved 15,000 shares at $8.49 per share.
Robert James Wills currently owns 32,241 shares of CymaBay Therapeutics, Inc. (CBAY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert James Wills's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert James Wills has 37 Form 4 filings on record as an insider at CymaBay Therapeutics, Inc..
Set alerts for Robert James Wills and 40,000+ other insiders.